NCT00444340View on ClinicalTrials.gov

An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

July 31, 2007

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Enbrel (Etanercept)

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00444340 - An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter